Ranbaxy has assured the public that drugs manufactured locally are safe days after the Indian firm paid a fine of $500 million in the US.

Under Daiichi, Ranbaxy is emerging as a less aggressive, less confrontational, less communicative and more Japanese and more healthy.

Japan's Daiichi Sankyo has named an executive with more than 25 years of experience to oversee the quality and manufacturing standards in R...